Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 15

MAFLD is Associated with the Risk of Liver Fibrosis and Inflammatory Activity in HBeAg-Negative CHB Patients

Total article views   HTML views PDF downloads Totals
6,871 Dovepress* 6,423+ 415 6,838
PubMed Central* 448 183 631
Totals 6,871 598 7,469
*Since 1 March 2022

View citations on PubMed Central and Google Scholar